Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Després J[au]:

Obesity. González-Muniesa P et al. Nat Rev Dis Primers. (2017)

Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome. de Toro-Martín J et al. Nutrients. (2017)

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Writing Group Members. et al. Circulation. (2016)

Search results

Items: 1 to 50 of 732

1.

Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine?

Després JP.

Nat Rev Cardiol. 2019 Nov 21. doi: 10.1038/s41569-019-0310-2. [Epub ahead of print] No abstract available.

PMID:
31754191
2.

Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease.

Anand SS, Tu JV, Desai D, Awadalla P, Robson P, Jacquemont S, Dummer T, Le N, Parker L, Poirier P, Teo K, Lear SA, Yusuf S, Tardif JC, Marcotte F, Busseuil D, Després JP, Black SE, Kirpalani A, Parraga G, Noseworthy MD, Dick A, Leipsic J, Kelton D, Vena J, Thomas M, Schulze KM, Larose E, Moody AR, Smith EE, Friedrich MG; Canadian Alliance for Healthy Hearts and Minds Cohort .

Eur Heart J Cardiovasc Imaging. 2019 Sep 30. pii: jez226. doi: 10.1093/ehjci/jez226. [Epub ahead of print]

PMID:
31565735
3.

One-Year Lifestyle Intervention, Muscle Lipids, and Cardiometabolic Risk.

Maltais A, Lemieux I, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP.

Med Sci Sports Exerc. 2019 Oct;51(10):2156-2165. doi: 10.1249/MSS.0000000000002030.

PMID:
31525173
4.

From syndrome X to cardiometabolic risk: clinical and public health implications.

Després JP.

Proc Nutr Soc. 2019 Jul 18:1-7. doi: 10.1017/S0029665119001010. [Epub ahead of print]

PMID:
31317841
5.

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10. Review.

6.

Assessing nutritional quality as a 'vital sign' of cardiometabolic health.

Buteau-Poulin D, Poirier P, Després JP, Alméras N.

Br J Nutr. 2019 Jul 28;122(2):195-205. doi: 10.1017/S0007114519001016. Epub 2019 Jun 25.

PMID:
31182170
7.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

8.

Deteriorated Cardiometabolic Risk Profile in Individuals With Excessive Blood Pressure Response to Submaximal Exercise.

Côté CE, Rhéaume C, Poirier P, Després JP, Alméras N.

Am J Hypertens. 2019 Sep 24;32(10):945-952. doi: 10.1093/ajh/hpz087.

PMID:
31136645
9.

Effect of PPARγ agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study.

Bastien M, Poirier P, Brassard P, Arsenault BJ, Bertrand OF, Després JP, Costerousse O, Piché ME.

Am J Physiol Endocrinol Metab. 2019 Jul 1;317(1):E65-E73. doi: 10.1152/ajpendo.00505.2018. Epub 2019 Apr 9.

PMID:
30964707
10.

Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity.

Gangloff A, Bergeron J, Lemieux I, Tremblay A, Poirier P, Alméras N, Després JP.

Int J Obes (Lond). 2019 Mar 29. doi: 10.1038/s41366-019-0347-7. [Epub ahead of print]

PMID:
30926948
11.

Twofold correlation spreading in a strongly correlated lattice Bose gas.

Despres J, Villa L, Sanchez-Palencia L.

Sci Rep. 2019 Mar 11;9(1):4135. doi: 10.1038/s41598-019-40679-3.

12.

Benefits of 1-Year Lifestyle Modification Program on Exercise Capacity and Diastolic Function Among Coronary Artery Disease Men With and Without Type 2 Diabetes.

Piché ME, Poirier P, Marette A, Mathieu P, Lévesque V, Bibeau K, Larose É, Després JP.

Metab Syndr Relat Disord. 2019 Apr;17(3):149-159. doi: 10.1089/met.2018.0092. Epub 2019 Feb 21.

PMID:
30789304
13.

Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials.

Rao S, Pandey A, Garg S, Park B, Mayo H, Després JP, Kumbhani D, de Lemos JA, Neeland IJ.

Mayo Clin Proc. 2019 Feb;94(2):211-224. doi: 10.1016/j.mayocp.2018.09.019.

PMID:
30711119
14.

Replicative senescence of human dermal fibroblasts affects structural and functional aspects of the Golgi apparatus.

Despres J, Ramdani Y, di Giovanni M, Bénard M, Zahid A, Montero-Hadjadje M, Yvergnaux F, Saguet T, Driouich A, Follet-Gueye ML.

Exp Dermatol. 2019 Aug;28(8):922-932. doi: 10.1111/exd.13886. Epub 2019 Mar 13.

PMID:
30659649
15.

Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels.

Carter S, Lemieux I, Li Z, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP, Picard F.

Atherosclerosis. 2019 Feb;281:89-97. doi: 10.1016/j.atherosclerosis.2018.12.016. Epub 2018 Dec 23.

16.

Cardiovascular Risk Factors Associated With Venous Thromboembolism.

Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, Bell S, Sweeting M, Rimm EB, Kabrhel C, Zöller B, Assmann G, Gudnason V, Folsom AR, Arndt V, Fletcher A, Norman PE, Nordestgaard BG, Kitamura A, Mahmoodi BK, Whincup PH, Knuiman M, Salomaa V, Meisinger C, Koenig W, Kavousi M, Völzke H, Cooper JA, Ninomiya T, Casiglia E, Rodriguez B, Ben-Shlomo Y, Després JP, Simons L, Barrett-Connor E, Björkelund C, Notdurfter M, Kromhout D, Price J, Sutherland SE, Sundström J, Kauhanen J, Gallacher J, Beulens JWJ, Dankner R, Cooper C, Giampaoli S, Deen JF, Gómez de la Cámara A, Kuller LH, Rosengren A, Svensson PJ, Nagel D, Crespo CJ, Brenner H, Albertorio-Diaz JR, Atkins R, Brunner EJ, Shipley M, Njølstad I, Lawlor DA, van der Schouw YT, Selmer RM, Trevisan M, Verschuren WMM, Greenland P, Wassertheil-Smoller S, Lowe GDO, Wood AM, Butterworth AS, Thompson SG, Danesh J, Di Angelantonio E, Meade T; Emerging Risk Factors Collaboration.

JAMA Cardiol. 2019 Feb 1;4(2):163-173. doi: 10.1001/jamacardio.2018.4537.

17.

COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners.

Meeraus W, Wood R, Jakubanis R, Holbrook T, Bizouard G, Despres J, Silva CCD, Nachbaur G, Landis SH, Punekar Y, Aguilaniu B, Ismaila AS.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 18;14:51-63. doi: 10.2147/COPD.S181224. eCollection 2019.

18.

Ectopic adiposity and cardiometabolic health in COPD.

Coats V, Després JP, Alméras N, Martin M, Sin DD, Rabasa-Lhoret R, Larose É, Tan WC, Bourbeau J, Maltais F; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 15;13:3331-3340. doi: 10.2147/COPD.S168963. eCollection 2018.

19.

Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association.

Johnson RK, Lichtenstein AH, Anderson CAM, Carson JA, Després JP, Hu FB, Kris-Etherton PM, Otten JJ, Towfighi A, Wylie-Rosett J; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Quality of Care and Outcomes Research; and Stroke Council.

Circulation. 2018 Aug 28;138(9):e126-e140. doi: 10.1161/CIR.0000000000000569. Review.

PMID:
30354445
20.

Response by Neeland et al to Letter Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".

Neeland IJ, Poirier P, Després JP.

Circulation. 2018 Oct 2;138(14):1496-1497. doi: 10.1161/CIRCULATIONAHA.118.036022. No abstract available.

21.

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.

Salaun E, Mahjoub H, Dahou A, Mathieu P, Larose É, Després JP, Rodés-Cabau J, Arsenault BJ, Puri R, Clavel MA, Pibarot P.

J Am Coll Cardiol. 2018 Jul 17;72(3):241-251. doi: 10.1016/j.jacc.2018.04.064. Epub 2018 Jul 9.

22.

Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.

Piché ME, Poirier P, Lemieux I, Després JP.

Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):103-113. doi: 10.1016/j.pcad.2018.06.004. Epub 2018 Jun 28. Review.

PMID:
29964067
23.

Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.

Boyer M, Mitchell PL, Poirier P, Alméras N, Tremblay A, Bergeron J, Després JP, Arsenault BJ.

Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E460-E468. doi: 10.1152/ajpendo.00127.2018. Epub 2018 Jun 5.

24.

Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.

Boyer M, Lévesque V, Poirier P, Marette A, Mitchell PL, Mora S, Mathieu P, Després JP, Larose É, Arsenault BJ.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e008681. doi: 10.1161/JAHA.118.008681.

25.

The relationship between adiposopathy and glucose-insulin homeostasis is not affected by moderate-intensity aerobic training in healthy women with obesity.

Clément AA, Riesco E, Tessier S, Lacaille M, Pérusse F, Coté M, Després JP, Weisnagel J, Doré J, Joanisse DR, Mauriège P.

J Physiol Biochem. 2018 Nov;74(4):591-601. doi: 10.1007/s13105-018-0630-4. Epub 2018 Apr 26.

PMID:
29696568
26.

The relationship between yogurt consumption, body weight, and metabolic profiles in youth with a familial predisposition to obesity.

Panahi S, Gallant A, Tremblay A, Pérusse L, Després JP, Drapeau V.

Eur J Clin Nutr. 2019 Apr;73(4):541-548. doi: 10.1038/s41430-018-0166-2. Epub 2018 Apr 25.

PMID:
29691489
27.

The Reaven syndrome: a tribute to a giant.

Després JP.

Nat Rev Endocrinol. 2018 Jun;14(6):319-320. doi: 10.1038/s41574-018-0013-5. No abstract available.

PMID:
29686431
28.

Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort.

Chau K, Girerd N, Magnusson M, Lamiral Z, Bozec E, Merckle L, Leosdottir M, Bachus E, Frikha Z, Ferreira JP, Després JP, Rossignol P, Boivin JM, Zannad F.

Clin Res Cardiol. 2018 Oct;107(10):887-896. doi: 10.1007/s00392-018-1259-6. Epub 2018 Apr 21.

PMID:
29680861
29.

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.

Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, Paul DS, Sweeting M, Burgess S, Bell S, Astle W, Stevens D, Koulman A, Selmer RM, Verschuren WMM, Sato S, Njølstad I, Woodward M, Salomaa V, Nordestgaard BG, Yeap BB, Fletcher A, Melander O, Kuller LH, Balkau B, Marmot M, Koenig W, Casiglia E, Cooper C, Arndt V, Franco OH, Wennberg P, Gallacher J, de la Cámara AG, Völzke H, Dahm CC, Dale CE, Bergmann MM, Crespo CJ, van der Schouw YT, Kaaks R, Simons LA, Lagiou P, Schoufour JD, Boer JMA, Key TJ, Rodriguez B, Moreno-Iribas C, Davidson KW, Taylor JO, Sacerdote C, Wallace RB, Quiros JR, Tumino R, Blazer DG 2nd, Linneberg A, Daimon M, Panico S, Howard B, Skeie G, Strandberg T, Weiderpass E, Nietert PJ, Psaty BM, Kromhout D, Salamanca-Fernandez E, Kiechl S, Krumholz HM, Grioni S, Palli D, Huerta JM, Price J, Sundström J, Arriola L, Arima H, Travis RC, Panagiotakos DB, Karakatsani A, Trichopoulou A, Kühn T, Grobbee DE, Barrett-Connor E, van Schoor N, Boeing H, Overvad K, Kauhanen J, Wareham N, Langenberg C, Forouhi N, Wennberg M, Després JP, Cushman M, Cooper JA, Rodriguez CJ, Sakurai M, Shaw JE, Knuiman M, Voortman T, Meisinger C, Tjønneland A, Brenner H, Palmieri L, Dallongeville J, Brunner EJ, Assmann G, Trevisan M, Gillum RF, Ford I, Sattar N, Lazo M, Thompson SG, Ferrari P, Leon DA, Smith GD, Peto R, Jackson R, Banks E, Di Angelantonio E, Danesh J; Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group.

Lancet. 2018 Apr 14;391(10129):1513-1523. doi: 10.1016/S0140-6736(18)30134-X. Erratum in: Lancet. 2018 Jun 2;391(10136):2212.

30.

Trunk muscle quality assessed by computed tomography: Association with adiposity indices and glucose tolerance in men.

Maltais A, Alméras N, Lemieux I, Tremblay A, Bergeron J, Poirier P, Després JP.

Metabolism. 2018 Aug;85:205-212. doi: 10.1016/j.metabol.2018.04.003. Epub 2018 Apr 12.

PMID:
29656048
31.

Hypertriglyceridemic Waist: A Simple Marker of High-Risk Atherosclerosis Features Associated With Excess Visceral Adiposity/Ectopic Fat.

LeBlanc S, Coulombe F, Bertrand OF, Bibeau K, Pibarot P, Marette A, Alméras N, Lemieux I, Després JP, Larose E.

J Am Heart Assoc. 2018 Apr 13;7(8). pii: e008139. doi: 10.1161/JAHA.117.008139.

32.

Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Neeland IJ, Poirier P, Després JP.

Circulation. 2018 Mar 27;137(13):1391-1406. doi: 10.1161/CIRCULATIONAHA.117.029617. Review.

33.

Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study.

Piché ME, Laberge AS, Brassard P, Arsenault BJ, Bertrand OF, Després JP, Costerousse O, Poirier P.

Diabetes Obes Metab. 2018 Jul;20(7):1740-1750. doi: 10.1111/dom.13293. Epub 2018 Apr 19.

PMID:
29573098
34.

ICP: From Correlation to Causation.

Schmidt EA, Maarek O, Despres J, Verdier M, Risser L.

Acta Neurochir Suppl. 2018;126:167-171. doi: 10.1007/978-3-319-65798-1_35.

PMID:
29492555
35.

ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.

Tastet L, Capoulade R, Shen M, Clavel MA, Côté N, Mathieu P, Arsenault M, Bédard É, Tremblay A, Samson M, Bossé Y, Dumesnil JG, Arsenault BJ, Beaudoin J, Bernier M, Després JP, Pibarot P.

J Am Heart Assoc. 2018 Feb 10;7(4). pii: e007980. doi: 10.1161/JAHA.117.007980.

36.

Impact of a non-restrictive satiating diet on anthropometrics, satiety responsiveness and eating behaviour traits in obese men displaying a high or a low satiety phenotype.

Arguin H, Tremblay A, Blundell JE, Després JP, Richard D, Lamarche B, Drapeau V.

Br J Nutr. 2017 Nov;118(9):750-760. doi: 10.1017/S0007114517002549.

37.

Relation Between a Simple Lifestyle Risk Score and Established Biological Risk Factors for Cardiovascular Disease.

Lévesque V, Poirier P, Després JP, Alméras N.

Am J Cardiol. 2017 Dec 1;120(11):1939-1946. doi: 10.1016/j.amjcard.2017.08.008. Epub 2017 Aug 30.

PMID:
28965712
38.

Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.

de Toro-Martín J, Arsenault BJ, Després JP, Vohl MC.

Nutrients. 2017 Aug 22;9(8). pii: E913. doi: 10.3390/nu9080913. Review.

39.

Obesity.

González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA.

Nat Rev Dis Primers. 2017 Jun 15;3:17034. doi: 10.1038/nrdp.2017.34. Review.

PMID:
28617414
40.

Targeting Overconsumption of Sugar-Sweetened Beverages vs. Overall Poor Diet Quality for Cardiometabolic Diseases Risk Prevention: Place Your Bets!

Arsenault BJ, Lamarche B, Després JP.

Nutrients. 2017 Jun 13;9(6). pii: E600. doi: 10.3390/nu9060600. Review.

41.

Yogurt consumption, body composition, and metabolic health in the Québec Family Study.

Panahi S, Doyon CY, Després JP, Pérusse L, Vohl MC, Drapeau V, Tremblay A.

Eur J Nutr. 2018 Jun;57(4):1591-1603. doi: 10.1007/s00394-017-1444-9. Epub 2017 Jun 2.

PMID:
28577150
42.

Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity.

Taskinen MR, Söderlund S, Bogl LH, Hakkarainen A, Matikainen N, Pietiläinen KH, Räsänen S, Lundbom N, Björnson E, Eliasson B, Mancina RM, Romeo S, Alméras N, Pepa GD, Vetrani C, Prinster A, Annuzzi G, Rivellese A, Després JP, Borén J.

J Intern Med. 2017 Aug;282(2):187-201. doi: 10.1111/joim.12632. Epub 2017 Jun 27.

43.

Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease.

LeBlanc S, Bibeau K, Bertrand OF, Lévesque V, Deschênes St-Pierre B, Pibarot P, Després JP, Larose E.

Can J Physiol Pharmacol. 2017 Aug;95(8):878-887. doi: 10.1139/cjpp-2016-0588. Epub 2017 May 18.

PMID:
28520469
44.

Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.

Matikainen N, Söderlund S, Björnson E, Bogl LH, Pietiläinen KH, Hakkarainen A, Lundbom N, Eliasson B, Räsänen SM, Rivellese A, Patti L, Prinster A, Riccardi G, Després JP, Alméras N, Holst JJ, Deacon CF, Borén J, Taskinen MR.

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):534-542. doi: 10.1016/j.numecd.2017.03.003. Epub 2017 Mar 18.

PMID:
28428027
45.

Mortality in the Familial Atherosclerosis Treatment Study-Observational Study.

Poirier P, Marette A, Després JP, Larose É, Arsenault BJ.

J Clin Lipidol. 2017 Jan - Feb;11(1):309-310. doi: 10.1016/j.jacl.2017.01.008. Epub 2017 Jan 23. No abstract available.

PMID:
28391906
46.

Overweight: The Body Mass Index Category With an Identity Crisis.

Després JP.

Ann Intern Med. 2017 May 2;166(9):671-672. doi: 10.7326/M17-0566. Epub 2017 Apr 4. No abstract available.

PMID:
28384686
47.

Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.

Capoulade R, Chan KL, Mathieu P, Bossé Y, Dumesnil JG, Tam JW, Teo KK, Yang X, Witztum JL, Arsenault BJ, Després JP, Pibarot P, Tsimikas S.

Atherosclerosis. 2017 May;260:1-7. doi: 10.1016/j.atherosclerosis.2017.03.013. Epub 2017 Mar 9.

PMID:
28319871
48.

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.

Martin M, Almeras N, Després JP, Coxson HO, Washko GR, Vivodtzev I, Wouters EF, Rutten E, Williams MC, Murchison JT, MacNee W, Sin DD, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:451-460. doi: 10.2147/COPD.S124750. eCollection 2017.

49.

Cardiovascular disease prevention: lifestyle attenuation of genetic risk.

Arsenault BJ, Després JP.

Nat Rev Cardiol. 2017 Apr;14(4):187-188. doi: 10.1038/nrcardio.2017.20. Epub 2017 Feb 16. No abstract available.

PMID:
28202900
50.

Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.

Borel AL, Nazare JA, Baillot A, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP.

Am J Physiol Endocrinol Metab. 2017 Apr 1;312(4):E273-E281. doi: 10.1152/ajpendo.00278.2016. Epub 2016 Dec 27.

Supplemental Content

Loading ...
Support Center